Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil

Open Access

Peer-reviewed

Research Article

Patrícia Coelho de Soárez ,

* E-mail: patricia.soarez@usp.br

Affiliation Departamento de Medicina Preventiva, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
⨯
Ana Marli Christovam Sartori,

Affiliation Clínica de Moléstias Infecciosas e Parasitárias, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
⨯
Angela Carvalho Freitas,

Affiliation Clínica de Moléstias Infecciosas e Parasitárias, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
⨯
Álvaro Mitsunori Nishikawa,

Affiliation Departamento de Medicina Preventiva, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
⨯
Hillegonda Maria Dutilh Novaes

Affiliation Departamento de Medicina Preventiva, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
⨯

Reader Comments (0)

Pneumonia
Is the Subject Area "Pneumonia" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Brazil
Is the Subject Area "Brazil" applicable to this article?

Thanks for your feedback.
Meningitis
Is the Subject Area "Meningitis" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Geriatric care
Is the Subject Area "Geriatric care" applicable to this article?

Thanks for your feedback.
Sepsis
Is the Subject Area "Sepsis" applicable to this article?

Thanks for your feedback.